Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FHL3 antibody (AA 1-280)

This anti-FHL3 antibody is a Rabbit Polyclonal antibody detecting FHL3 in WB, ELISA and IHC. Suitable for Human.
Catalog No. ABIN7153138

Quick Overview for FHL3 antibody (AA 1-280) (ABIN7153138)

Target

See all FHL3 Antibodies
FHL3 (Four and A Half LIM Domains 3 (FHL3))

Reactivity

  • 19
  • 13
  • 6
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 16
  • 2
  • 1
Rabbit

Clonality

  • 18
  • 1
Polyclonal

Conjugate

  • 12
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FHL3 antibody is un-conjugated

Application

  • 11
  • 6
  • 3
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1-280

    Cross-Reactivity

    Human

    Purification

    Antigen Affinity Purified

    Immunogen

    Recombinant Human Four and a half LIM domains protein 3 protein (1-280AA)

    Isotype

    IgG
  • Application Notes

    Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    FHL3 (Four and A Half LIM Domains 3 (FHL3))

    Alternative Name

    FHL3

    Background

    Background: focal adhesion, muscle organ development

    Aliases: FHL 3 antibody, FHL-3 antibody, Fhl3 antibody, FHL3_HUMAN antibody, Four and a half LIM domains 3 antibody, Four and a half LIM domains protein 3 antibody, Skeletal muscle LIM protein 2 antibody, Skeletal muscle LIM-protein 2 antibody, SLIM-2 antibody, SLIM2 antibody

    UniProt

    Q13643
You are here:
Chat with us!